Highlights From ESMO Gastrointestinal Cancers Congress 2025
Following are key take‑home messages from ESMO GI 2025 (Barcelona, 2–5 July), organized by cancer type.
Highlights From ESMO Gastrointestinal Cancers Congress 2025 Read More »
Following are key take‑home messages from ESMO GI 2025 (Barcelona, 2–5 July), organized by cancer type.
Highlights From ESMO Gastrointestinal Cancers Congress 2025 Read More »
This collection highlights real stories of stage 4 colorectal cancer patients with extensive metastases who achieved long-term survival through multiple lines of treatment—options often not fully detailed in standard guidelines.
CASE SELECTION 2: Long-Term Survival with Extensively Metastatic Colorectal Cancer Read More »
The American Society of Clinical Oncology (ASCO) 2025 annual meeting, held from May 30 to June 3, 2025, featured significant clinical developments across multiple cancer treatment modalities, with particular attention to antibody-drug conjugates (ADCs), CAR-T cell therapies, and immuno-oncology agents.
ASCO 2025 Highlights: Key Clinical Developments and Regulatory Updates Read More »
Liver metastases represent a significant challenge in colorectal cancer (CRC) management, affecting approximately 20% of patients at initial diagnosis (synchronous) and up to 60% during disease progression (metachronous). This report synthesizes current treatment recommendations from major oncology organizations including ASCO, NCCN, and ESMO, highlighting evidence-based approaches based on disease presentation and therapeutic goals.
Treatment Options for Liver Metastases in Colorectal Cancer: Guidelines Summary Read More »
A 44-year-old patient diagnosed with stage IV colorectal cancer amid COVID-19 fought for a timely colonoscopy, embraced lifestyle changes, and joined an innovative drug trial—resulting in dramatic tumor reduction and a powerful advocacy journey
A Determined Fight Against Stage IV Colorectal Cancer Read More »
Recent breakthrough research has revealed promising news for colorectal cancer survivors with specific genetic mutations, suggesting that a simple daily aspirin could significantly reduce cancer recurrence. This development represents a potential paradigm shift in post-treatment care for a substantial subset of colorectal cancer patients, offering an inexpensive and accessible intervention with remarkable efficacy. Understanding Aspirin’s
Preventing Colorectal Cancer Recurrence: Latest Findings on Low-Dose Aspirin Therapy Read More »
Discover how humor and determination helped Sonya overcome Stage IV colorectal cancer, stay strong for her children, and celebrate five years cancer-free.
Beating Stage IV Colorectal Cancer with Laughter and Love Read More »
Discover how Trent overcame a stage IV colon cancer diagnosis, harnessing innovative immunotherapy and his lifelong passion for cycling to reclaim his health and ride 6,000 miles in a single year.
An Unstoppable Ride: Hope Beyond Stage IV Colon Cancer Read More »
Discover how Ida overcame a terminal Stage IV colorectal cancer diagnosis through surgery, clinical trials, and unwavering hope—emerging cancer-free and ready to explore the world.
From “Terminal” to Cancer-Free: A Remarkable Stage IV Rectal Cancer Journey Read More »
Discover how Patrick overcame the shock of a stage IV colorectal cancer diagnosis—enduring multiple surgeries, a stoma, and chemo—while ultimately finding purpose through advocacy and awareness.
Embracing Life With Stage IV colorectal Cancer Read More »